Company Description
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips.
It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies.
In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services.
The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
| Country | United States |
| Founded | 1904 |
| IPO Date | May 17, 2019 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 13,500 |
| CEO | Emmanuel Ligner |
Contact Details
Address: Radnor Corporate Center, Building One Radnor, Pennsylvania 19087 United States | |
| Phone | 610 386 1700 |
| Website | avantorsciences.com |
Stock Details
| Ticker Symbol | AVTR |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $14.00 |
| CIK Code | 1722482 |
| CUSIP Number | 05352A100 |
| ISIN Number | US05352A1007 |
| Employer ID | 82-2758923 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Emmanuel Ligner | President, Chief Executive Officer and Director |
| Claudius O. Sokenu | Executive Vice President, Corporate Secretary and Chief Legal and Compliance Officer |
| Corey D. Walker | President of Laboratory Solutions |
| Benoit Gourdier | Executive Vice President of Bioscience Production |
| Mary Blenn | Executive Vice President and Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 21, 2026 | 8-K | Current Report |
| Sep 21, 2026 | 8-K | Current Report |
| Aug 27, 2026 | 8-K/A | [Amend] Current report |
| Jul 29, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 17, 2026 | 8-K | Current Report |
| May 29, 2026 | SD | Form - SD |
| May 12, 2026 | 8-K | Current Report |
| Apr 29, 2026 | SCHEDULE 13G | Filing |
| Apr 29, 2026 | 10-Q | Quarterly Report |